ALEXANDRIA, Va., Aug. 25 -- United States Patent no. 12,714,674, issued on Aug. 25, was assigned to Elanco US Inc. (Indianapolis).
"JAK inhibitors having a specific particle size distribution" was invented by Stephen Stirm (Indianapolis).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides compositions of 2-(3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-1-(cyclopropylsulfonyl)azetidin-3-yl)acetonitrile having a specific acceptance value and/or particle size distribution, pharmaceutical compositions comprising the same, methods of using the same, and processes for making the same."
The patent was filed on Oct. 25, 2021, under Application No. 18/249,869.
*For further inform...